NO20003261L - Blandinger avledet fra Mycobacterium vaccae og fremgangsmÕter for deres anvendelse - Google Patents

Blandinger avledet fra Mycobacterium vaccae og fremgangsmÕter for deres anvendelse

Info

Publication number: NO20003261L
Authority: NO; Norway
Prior art keywords: vaccae; methods; delipidated; mycobacterium vaccae; mixtures derived
Prior art date: 1997-12-23

Application number

NO20003261A

Other languages

English (en)

Norwegian (no)

Other versions

NO20003261D0 (no

Inventor

Paul Tan

James Watson

Elizabeth S Visser

Margot A Skinner

Ross L Prestidge

Original Assignee

Genesis Research & Dev Corp Lt

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-23

Filing date

2000-06-22

Publication date

2000-08-22

1997-12-23 Priority claimed from US08/997,080 external-priority patent/US5968524A/en

1997-12-23 Priority claimed from US08/997,362 external-priority patent/US5985287A/en

1998-06-11 Priority claimed from US09/095,855 external-priority patent/US6160093A/en

1998-12-04 Priority claimed from US09/205,426 external-priority patent/US6406704B1/en

2000-06-22 Application filed by Genesis Research & Dev Corp Lt filed Critical Genesis Research & Dev Corp Lt

2000-06-22 Publication of NO20003261D0 publication Critical patent/NO20003261D0/no

2000-08-22 Publication of NO20003261L publication Critical patent/NO20003261L/no

Links

241000187644 Mycobacterium vaccae Species 0.000 title abstract 5
238000000034 method Methods 0.000 title abstract 3
239000000203 mixture Substances 0.000 title 1
239000002253 acid Substances 0.000 abstract 2
150000007513 acids Chemical class 0.000 abstract 2
SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 abstract 1
229920000189 Arabinogalactan Polymers 0.000 abstract 1
239000001904 Arabinogalactan Substances 0.000 abstract 1
208000035473 Communicable disease Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
235000019312 arabinogalactan Nutrition 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
238000001514 detection method Methods 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
239000000706 filtrate Substances 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
208000026278 immune system disease Diseases 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Oncology (AREA)
Genetics & Genomics (AREA)
Mycology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

NO20003261A 1997-12-23 2000-06-22 Blandinger avledet fra Mycobacterium vaccae og fremgangsmÕter for deres anvendelse NO20003261L (no)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US99662497A	1997-12-23	1997-12-23
US08/997,080 US5968524A (en)	1997-12-23	1997-12-23	Methods and compounds for the treatment of immunologically-mediated psoriasis
US08/997,362 US5985287A (en)	1996-08-29	1997-12-23	Compounds and methods for treatment and diagnosis of mycobacterial infections
US09/095,855 US6160093A (en)	1996-08-29	1998-06-11	Compounds and methods for treatment and diagnosis of mycobacterial infections
US15618198A	1998-09-17	1998-09-17
US09/205,426 US6406704B1 (en)	1996-08-29	1998-12-04	Compounds and methods for treatment and diagnosis of mycobacterial infections
PCT/NZ1998/000189 WO1999032634A2 (en)	1997-12-23	1998-12-23	Compositions derived from mycobacterium vaccae and methods for their use

Publications (2)

Publication Number	Publication Date
NO20003261D0 NO20003261D0 (no)	2000-06-22
NO20003261L true NO20003261L (no)	2000-08-22

Family

ID=27557521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20003261A NO20003261L (no)	1997-12-23	2000-06-22	Blandinger avledet fra Mycobacterium vaccae og fremgangsmÕter for deres anvendelse

Country Status (15)

Country	Link
EP (1)	EP1044273A2 (id)
JP (1)	JP2002514385A (id)
CN (1)	CN1294632A (id)
AU (1)	AU746311B2 (id)
BR (1)	BR9814432A (id)
CA (1)	CA2315539A1 (id)
HU (1)	HUP0100352A2 (id)
ID (1)	ID26327A (id)
IL (1)	IL136821A0 (id)
MX (1)	MXPA00006168A (id)
NO (1)	NO20003261L (id)
NZ (1)	NZ505834A (id)
PL (1)	PL341697A1 (id)
TR (1)	TR200001948T2 (id)
WO (1)	WO1999032634A2 (id)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6569436B1 (en)	1998-10-05	2003-05-27	The Malaghan Institute Of Medical Research	Method of using a vaccine
JP4415200B2 (ja) *	1999-01-29	2010-02-17	大塚製薬株式会社	遅発育性抗酸菌ポリペプチド
GB9903539D0 (en)	1999-02-16	1999-04-07	Stanford Rook Ltd	Therapy using M.Vaccae
US6462669B1 (en)	1999-04-06	2002-10-08	E. P . Survivors Llc	Replaceable LED modules
US6350457B1 (en) *	1999-06-02	2002-02-26	Genesis Research & Development Corporation Limited	Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
AU784847B2 (en) *	1999-07-12	2006-07-06	Genesis Research And Development Corporation Limited	Compounds for treatment of infectious and immune system disorders and methods for their use
EP1208207A2 (de) *	1999-08-31	2002-05-29	Michael Niederweis	Verfahren zur herstellung eines kanalbildenden proteins
NZ517409A (en)	1999-08-31	2004-05-28	Novozymes As	RP-II properties with amino acid substitutions used in detergent compositions and additives
US7217554B2 (en)	1999-08-31	2007-05-15	Novozymes A/S	Proteases and variants thereof
US6361776B1 (en) *	1999-12-06	2002-03-26	Genesis Research & Development Corp. Ltd.	Compounds isolated from M. vaccae and their use in modulation of immune responses
US20030108527A1 (en) *	1999-12-28	2003-06-12	Tsukasa Seya	Maturation-promoting agent for immature dendrtic cells
AUPQ761200A0 (en) *	2000-05-19	2000-06-15	Hunter Immunology Limited	Compositions and methods for treatment of mucosal infections
US20030104012A1 (en) *	2001-05-11	2003-06-05	Corixa Corporation	Vaccines for the treatment of autoimmune disease
US20030147861A1 (en) *	2001-07-26	2003-08-07	Genesis Research And Development Corporation Limited	Compounds and methods for the modulation of immune responses
AU2002353366A1 (en) *	2001-12-10	2003-06-23	Bakulesh Mafatlal Khamar	The process of manufacturing a pharmaceutical composition useful for management of cancer
GB0303507D0 (en) *	2003-02-14	2003-03-19	Novartis Ag	Organic compounds
US10765731B2 (en) *	2014-01-09	2020-09-08	Transgene Sa	Fusion of heterooligomeric mycobacterial antigens
CN115804834B (zh) *	2021-08-10	2025-10-21	昆明医科大学	一种具有提高免疫力和抗肿瘤以及延长寿命的多肽及其应用
CN119162167B (zh) *	2024-11-21	2025-03-11	四川大学华西医院	一种分枝杆菌基因组的提取方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8919321D0 (en) *	1989-08-25	1989-10-11	Univ London	Treatment of chronic inflammatory conditions
GB9203814D0 (en) *	1992-02-21	1992-04-08	Univ London	Treatment of long term auto-immune conditions
US6284255B1 (en) *	1996-08-29	2001-09-04	Genesis Research & Development Corporation Limited	Compounds and methods for treatment and diagnosis of mycobacterial infections

1998
- 1998-12-23 NZ NZ505834A patent/NZ505834A/xx unknown
- 1998-12-23 MX MXPA00006168A patent/MXPA00006168A/es unknown
- 1998-12-23 CN CN98813781A patent/CN1294632A/zh active Pending
- 1998-12-23 TR TR2000/01948T patent/TR200001948T2/xx unknown
- 1998-12-23 JP JP2000525553A patent/JP2002514385A/ja active Pending
- 1998-12-23 IL IL13682198A patent/IL136821A0/xx unknown
- 1998-12-23 BR BR9814432-4A patent/BR9814432A/pt not_active IP Right Cessation
- 1998-12-23 EP EP98963665A patent/EP1044273A2/en not_active Withdrawn
- 1998-12-23 WO PCT/NZ1998/000189 patent/WO1999032634A2/en not_active Ceased
- 1998-12-23 CA CA002315539A patent/CA2315539A1/en not_active Abandoned
- 1998-12-23 HU HU0100352A patent/HUP0100352A2/hu unknown
- 1998-12-23 PL PL98341697A patent/PL341697A1/xx unknown
- 1998-12-23 ID IDW20001433A patent/ID26327A/id unknown
- 1998-12-23 AU AU18936/99A patent/AU746311B2/en not_active Ceased
2000
- 2000-06-22 NO NO20003261A patent/NO20003261L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ID26327A (id)	2000-12-14
IL136821A0 (en)	2001-06-14
CN1294632A (zh)	2001-05-09
AU746311B2 (en)	2002-04-18
HUP0100352A2 (hu)	2001-06-28
WO1999032634A3 (en)	1999-12-02
TR200001948T2 (tr)	2001-02-21
JP2002514385A (ja)	2002-05-21
CA2315539A1 (en)	1999-07-01
BR9814432A (pt)	2000-10-10
WO1999032634A2 (en)	1999-07-01
MXPA00006168A (es)	2005-02-24
NO20003261D0 (no)	2000-06-22
NZ505834A (en)	2002-12-20
PL341697A1 (en)	2001-04-23
EP1044273A2 (en)	2000-10-18
AU1893699A (en)	1999-07-12

Legal Events

Date	Code	Title	Description
2004-10-11	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NZ505834A (en)	2002-12-20	Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use
NO986173L (no)	1999-03-10	FremgangsmÕte for aktivering av dendrittceller
ATE326479T1 (de)	2006-06-15	Varianten von antigenen des menschlichen papillomvirus
NO20064388L (no)	2006-11-28	Kaseinavledede peptider og terapeutiske anvendelser derav
BR9907283A (pt)	2000-10-24	Vìrus do herpes simples, uso de um vìrus do herpes simples, composição farmacêutica, e, processos para estudar a função de gene heterólogo em uma célula de mamìfero e para produzir um vìrus do herpes simples
DE69929232D1 (de)	2006-02-02	Virusähnliche partikel zur induktion von autoantikörpern
BR9913446A (pt)	2004-03-02	Produtos de aglicona e métodos de uso
IL130931A0 (en)	2001-01-28	Small molecules useful in the treatment of inflammatory disease
WO1998008542A3 (en)	1998-07-09	Compounds and methods for treatment and diagnosis of mycobacterial infections
WO1998033527A3 (en)	1998-11-05	Cancer immunotherapy with semi-allogeneic cells
DE68915165D1 (de)	1994-06-09	Schimärische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
NO940661L (no)	1994-04-19	Peptider for indusering av cytotoksisk T-lymfocytreaksjoner mot hepatit B virus
TR199901003T2 (xx)	1999-07-21	Ast�m tedavisi i�in loratadin ve bir dekonjestan i�eren bile�im.
NO920331L (no)	1992-01-24	Biologisk preparat samt bruk derav
NO892125D0 (no)	1989-05-26	Kombinasjon av angiotensin-omvandlende-enzymhemmere med kaliumkanal-modulatorer samt deres anvendelse i legemidler.
DE69839943D1 (de)	2008-10-09	Verhinderung von immunreaktivität durch verarmung oder inhibition von antigen-präsentierenden zellen
DK540586A (da)	1987-05-14	Cardiotonisk virksomme thiazoloner
CA2273848A1 (en)	1998-06-25	Mycobacterium vaccae for down-regulation of the th2 activity of the immune system
NO922422L (no)	1992-08-17	Matrise med adherent bundede celler, samt fremgangsmaate ved fremstilling av virus/virusantigener
DE69106141D1 (de)	1995-02-02	Non-a non-b sequenzen.
PT87940A (pt)	1989-06-30	Processo para a preparacao de dna do virus papillom humano tipo 41 e de proteinas por ele codificadas
DK1313850T3 (da)	2008-12-01	Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer
AU5489500A (en)	2001-01-02	Isolation of a human retrovirus
DEUTSCH et al.	1964	Serological Demonstration of Antigenic Heterogeneity of Individual Human Î³1-Macroglobulins
MXPA03000542A (es)	2004-09-10	Metodos para el diagnostico y/o tratamiento de enfermedades relacionadas con anticuerpos antifosfolipidos, y dispositivos utilizados.